Correlation between plasma miR-122 expression and liver injury induced by hepatectomy

Journal of International Medical Research

Volumn 42, Issue 1, 2014, Pages 77-84

  Ruoquan, Yao ^a   Wanpin, Nie ^a   Qiangsheng, Xiao ^a   Guodong, Tian ^a   Feizhou, Huang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

hepatectomy; Liver cancer; liver injury; microRNA 122

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; MICRORNA 122;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLEEDING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME ACTIVITY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; TUMOR VOLUME;

HEPATECTOMY; LIVER CANCER; LIVER INJURY; MICRORNA-122;

ADULT; ALANINE TRANSAMINASE; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84892463405     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513499093     Document Type: Article

References (36)

1. El-Serag HB,Rudolph KL.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.Gastroenterology. 2007;132:2557-2576.
2. Fan ST,Lo CM,Liu CL, et al.Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.Ann Surg. 1999;229:322-330.
3. Otsubo T,Takasaki K,Yamamoto M, et al.Bleeding during hepatectomy can be reduced by clamping the inferior vena cava below the liver.Surgery. 2004;135:67-73.
4. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004;116:281-297.
5. Fichtlscherer S,Zeiher AM,Dimmeler S.Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?.Arterioscler Thromb Vasc Biol. 2011;31:2383-2390.
6. Chen X,Ba Y,Ma L, et al.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res. 2008;18:997-1006.
7. Ivey KN,Srivastava D.MicroRNAs as regulators of differentiation and cell fate decisions.Cell Stem Cell. 2010;7:36-41.
8. Ivey KN,Muth A,Arnold J, et al.MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.Cell Stem Cell. 2008;2:219-229.
9. Schonrock N,Ke YD,Humphreys D, et al.Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.PloS One. 2010;5:e11070-e11070.
10. Esau C,Davis S,Murray SF, et al.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.Cell Metab. 2006;3:87-98.
11. Coulouarn C,Factor VM,Andersen JB, et al.Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.Oncogene. 2009;28:3526-3536.
12. Gatfield D,Le Martelot G,Vejnar CE, et al.Integration of microRNA miR-122 in hepatic circadian gene expression.Genes Dev. 2009;23:1313-1326.
13. Chang J,Guo JT,Jiang D, et al.Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells.J Virol. 2008;82:8215-8223.
14. Castoldi M,Vujic Spasic M,Altamura S, et al.The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.J Clin Invest. 2011;121:1386-1386.
15. Laterza OF,Lim L,Garrett-Engele PW, et al.Plasma microRNAs as sensitive and specific biomarkers of tissue injury.Clin Chem. 2009;55:1977-1983.
16. Wang K,Zhang S,Marzolf B, et al.Circulating microRNAs, potential biomarkers for drug-induced liver injury.Proc Natl Acad Sci U S A. 2009;106:4402-4407.
17. Zhang Y,Jia Y,Zheng R, et al.Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.Clin Chem. 2010;56:1830-1838.
18. Miyagawa S,Makuuchi M,Kawasaki S, et al.Criteria for safe hepatic resection.Am J Surgery. 1995;169:589-594.
19. Wu X,Wu S,Tong L, et al.MiR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.Scand J Gastroenterol. 2009;44:1332-1339.
20. Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.Methods. 2001;25:402-408.
21. Férard G,Piton A,Messous D, et al.Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.Clin Chem Lab Med. 2006;44:400-406.
22. Imbert-Bismut F,Messous D,Thibault V, et al.Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.Clin Chem Lab Med. 2004;42:323-333.
23. Williams AE.Functional aspects of animal microRNAs.Cell Mol Life Sci. 2008;65:545-562.
24. Carthew RW,Sontheimer EJ.Origins and mechanisms of miRNAs and siRNAs.Cell. 2009;136:642-655.
25. Budhu A,Jia HL,Forgues M, et al.Identification of metastasis-related microRNAs in hepatocellular carcinoma.Hepatology. 2008;47:897-907.
26. Gramantieri L,Ferracin M,Fornari F, et al.Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.Cancer Res. 2007;67:6092-6099.
27. Lin CJ,Gong HY,Tseng HC, et al.miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.Biochem Biophys Res Commun. 2008;375:315-320.
28. Wang K,Zhang S,Marzolf B, et al.Circulating microRNAs, potential biomarkers for drug-induced liver injury.Proc Natl Acad Sci U S A. 2009;106:4402-4407.
29. Mitchell PS,Parkin RK,Kroh EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci U S A. 2008;105:10513-10518.
30. Scherrer K,Marcaud L,Zajdela F, et al.Patterns of RNA metabolism in a differentiated cell: a rapidly labeled, unstable 60S RNA with messenger properties in duck erythroblasts.Proc Natl Acad Sci U S A. 1966;56:1571-1578.
31. Smith B,Selby P,Southgate J, et al.Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.Lancet. 1991;338:1227-1229.
32. Murakami Y,Yasuda T,Saigo K, et al.Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumourous tissues.Oncogene. 2006;25:2537-2545.
33. McDonald JS,Milosevic D,Reddi HV, et al.Analysis of circulating microRNA: preanalytical and analytical challenges.Clin Chem. 2011;57:833-840.
34. Turchinovich A,Weiz L,Langheinz A, et al.Characterization of extracellular circulating microRNA.Nucleic Acids Res. 2011;39:7223-7233.
35. Eis PS,Tam W,Sun L, et al.Accumulation of miR-155 and BIC RNA in human B cell lymphomas.Proc Natl Acad Sci U S A. 2005;102:3627-3632.
36. Li C,Feng Y,Coukos G, et al.Therapeutic microRNA strategies in human cancer[J].The AAPS journal. 2009;11:747-757.